SOURCE: StockCall

StockCall

June 17, 2011 08:27 ET

Research on Novartis AG and Merck & Co. Inc. - Drug Major's Looking to Bolster Revenue, Plus Troubles From UNICEF

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Jun 17, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drug Manufacturers - Major industry and has completed analytical research on Novartis AG (NYSE: NVS) and Merck & Co. Inc. (NYSE: MRK). Register with us today at www.stockcall.com/ to have free access to these researches.

The looming patent cliff has many companies throughout the Drug Manufacturers- Major Sector looking for ways to bolster their product pipelines. Mergers, acquisitions, and partnerships have all been employed as strategies toward this aim. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drug Manufacturers - Major industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drug Manufacturers - Major industry can have easy and free access to our analyst research and opinions on Novartis AG and Merck & Co. Inc.; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

Merck & Co. Inc., for example, has formed a partnership with Roche Holding AG to develop diagnostic tests. Medical test making has become more attractive to Big Pharma now that the aging population of baby boomers is entering into the peak age for health care needs. Investors can register for free to access the research report on Merck & Co. Inc. at www.stockcall.com/MRK170611.pdf.

One major piece of news for the sector was the recent release of vaccine pricing information by UNICEF. The report showed big discrepancies in the prices charged by different drug companies. This could cause major cuts to pricing for companies in the sector, a victory for humanitarian groups, but a potential headwind to the sector's bottom-line. Companies like Novartis AG have resisted UNICEF's request to post their prices publicly because they deem the information competitive. Investors can register for free to access the research report on Novartis AG Inc. at www.stockcall.com/NVS170611.pdf.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information